Chicago Partners Investment Group’s Blueprint Medicines BPMC Stock Holding History

Chicago Partners Investment Group’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$12K	–	404
2018 Q3	$12K	Hold	200	–	–	﹤0.01%	773
2018 Q2	$13K	Hold	200	–	–	﹤0.01%	741
2018 Q1	$18K	Hold	200	–	–	﹤0.01%	658
2017 Q4	$15K	Hold	200	–	–	﹤0.01%	677
2017 Q3	$14K	Buy	+200	New	+$10.7K	﹤0.01%	711
2017 Q2	–	Sell	-200	Closed	-$8K	–	655
2017 Q1	$8K	Hold	200	–	–	﹤0.01%	465
2016 Q4	$6K	Hold	200	–	–	﹤0.01%	455
2016 Q3	$6K	Hold	200	–	–	﹤0.01%	449
2016 Q2	$4K	Hold	200	–	–	﹤0.01%	409
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	391
2015 Q4	$5K	Hold	200	–	–	﹤0.01%	444
2015 Q3	$4K	Hold	200	–	–	﹤0.01%	391
2015 Q2	$5K	Buy	+200	New	+$5.71K	﹤0.01%	394

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Chicago Partners Investment Group's BPMC Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Blueprint Medicines (BPMC) in Q4 2018, closing a stake of 200 shares — an estimated $12K sold.

Chicago Partners Investment Group first reported a position in BPMC in Q2 2015 and held it in 13 quarters. The position peaked at $18K in Q1 2018. 162 funds tracked by Wall St. Rank hold BPMC as of Q4 2018.

Chicago Partners Investment Group reported no remaining Blueprint Medicines position as of Q4 2018 after selling out during the quarter.
Chicago Partners Investment Group sold 200 Blueprint Medicines shares in Q4 2018, an estimated $12K.
Chicago Partners Investment Group first reported a position in Blueprint Medicines in Q2 2015 and held it in 13 quarters.
Chicago Partners Investment Group's Blueprint Medicines position peaked at $18K in Q1 2018.
162 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.